Compare RYAM & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RYAM | HQL |
|---|---|---|
| Founded | 1926 | 1992 |
| Country | United States | United States |
| Employees | 2350 | N/A |
| Industry | Paper | Investment Managers |
| Sector | Basic Materials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.8M | 492.8M |
| IPO Year | 2014 | N/A |
| Metric | RYAM | HQL |
|---|---|---|
| Price | $10.26 | $15.91 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 135.5K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | ★ 62.42 | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $1,630,308,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.99 | N/A |
| P/E Ratio | ★ N/A | $20.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.35 | $10.55 |
| 52 Week High | $11.05 | $17.80 |
| Indicator | RYAM | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 64.11 | 34.09 |
| Support Level | $7.09 | $15.67 |
| Resistance Level | N/A | $17.51 |
| Average True Range (ATR) | 0.74 | 0.30 |
| MACD | 0.22 | -0.10 |
| Stochastic Oscillator | 80.77 | 6.47 |
Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.